Article
Striatin genotype-based, mineralocorticoid receptor antagonist-driven clinical trial: study rationale and design.
Pharmacogenetics and genomics - 1 Jun 2021
Stone Isabella B, Green Jessica A E M, Koefoed Andrew W, Hornik Ezra S, Williams Jonathan S, Adler Gail K, Williams Gordon H
Abstract excerpt
OBJECTIVES: In human studies and genetically altered mouse studies, variants in the striatin gene (STRN) are associated with increased blood pressure (BP) and aldosterone on a liberal salt diet. This clinical trial is based on the presumed mechanism for striatin-associated HTN - increased aldosterone. It is designed to determine if participants with the STRN risk alleles will have a greater BP reduction on a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
